Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Nasal airflow to ease breathing for tracheostomized patients on ventilators

Official title: Nasal Airflow to Modulate Dyspnea in Tracheostomized Patients

Run by Assistance Publique - Hôpitaux de Paris · NCT07308171 · Data updated 2026-11-12

This study tests three non-drug methods to restore nasal stimulation and see if they reduce breathlessness in adults with tracheostomies who are dependent on mechanical ventilation.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment24 (estimated)
SponsorAssistance Publique - Hôpitaux de Paris
Academic / other
Locations1 site (Paris)
StatusRecruiting
StartedFebruary 17, 2026
Main results expectedFebruary 2028
Study endsFebruary 2028
Registry record updatedSeptember 29, 2026
Trial IDNCT07308171 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with tracheostomy who are dependent on mechanical ventilation and report dyspnea (≥3).

Probably not a fit

Patients without measurable improvement in dyspnea or who do not respond to nasal stimulation strategies may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial compares continuous nasal airflow, nasal sprays, and facial airflow to determine their effect on dyspnea and respiratory drive in tracheotomized patients on mechanical ventilation. It is an interventional study that assesses non-pharmacological approaches to restore nasal stimulation as a potential means to improve comfort during weaning. Participants are adults with tracheostomies, on ventilation, and reporting dyspnea, and are evaluated across baseline and three intervention conditions. The study is conducted at Hôpital Pitié-Salpêtrière in Paris under Assistance Publique - Hôpitaux de Paris.

Why it matters

Potential benefit: If successful, patients may experience reduced breathlessness and improved comfort during weaning from ventilation.

How similar studies have gone: Prior non-pharmacological approaches to enhance nasal stimulation have shown signals of benefit in related respiratory discomfort contexts, but this exact comparison is relatively novel in ventilated tracheostomized patients.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥ 18 years
2. Tracheostomy and mechanical ventilation
3. Dyspnea ≥3
4. Consent to participate
5. Affiliation to health insurance

Exclusion Criteria:

1. Agitation, delirium
2. Continuous use of sedatives
3. Patients under law protection
4. Inmates
5. Patients without health insurance
6. Breastfeeding and pregnancy

Where it's running

  • Hôpital Pitié Salpêtrière
    Paris, France
    Recruiting

Study contacts

  • Principal investigator: Martin Dres, MD PhD — Assistance Publique - Hôpitaux de Paris
  • Study coordinator: Martin DRES, MD PhD
  • Email: martin.dres@aphp.fr
  • Phone: +33142167809

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.